Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9 | 32 | 6 | 516 | 353 |
| Receivables | 7 | 6 | 5 | 16 | 9 |
| TOTAL | $38 | $73 | $33 | $546 | $384 |
| Non-Current Assets | |||||
| PPE Net | 463 | 509 | 556 | 602 | 599 |
| Intangibles | 945 | 964 | 983 | 1,001 | 1,020 |
| Other Non-Current Assets | 34 | 34 | 46 | 46 | 46 |
| TOTAL | $1,442 | $1,507 | $1,584 | $1,650 | $1,665 |
| Total Assets | $1,481 | $1,580 | $1,617 | $2,196 | $2,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,284 | 2,284 | 1,994 | 2,070 | 2,194 |
| Accrued Expenses | 1,835 | 1,702 | 2,257 | 2,308 | 2,079 |
| TOTAL | $6,059 | $5,845 | $5,549 | $5,698 | $5,590 |
| Non-Current Liabilities | |||||
| Long Term Debt | 138 | 298 | 487 | 499 | N/A |
| Other Non-Current Liabilities | 6 | 438 | 52 | 3 | 0 |
| TOTAL | $143 | $735 | $539 | $503 | $N/A |
| Total Liabilities | $6,202 | $6,580 | $6,088 | $6,201 | $5,590 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 2 | 1 | 1 | 1 |
| Common Shares | 5 | 5 | 4 | 4 | 4 |
| Retained earnings | -44,746 | -41,960 | -39,903 | -38,069 | -35,811 |
| Other shareholders' equity | 0 | 0 | 0 | -49 | -32 |
| TOTAL | $-4,722 | $-5,000 | $-4,471 | $-4,005 | $-3,541 |
| Total Liabilities And Equity | $1,481 | $1,580 | $1,617 | $2,196 | $2,050 |